Yahoo! Finance Search - Finance Home - Yahoo! - Help

Monday, August 3 2015 12:42am ET - U.S. Markets open in 8 hours and 48 minutes.
Industry Center - Drugs - Generic
Industry Center > Drugs - Generic > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drugs - Generic News
Latest News
Saturday, Aug 1, 2015
·Allergan is Cramer's Favorite Stock, Teva Deal Was 'Incredible'
at TheStreet.com - Sat 9:15 am ET
Friday, Jul 31, 2015
·Citing hacking risk, FDA says Hospira pump shouldn't be used
AP - Fri Jul 31
·FDA says hospitals should stop using Hospira pump
AP - Fri Jul 31
·FDA warns of security flaw in Hospira infusion pumps
Reuters - Fri Jul 31
·Mallinckrodt deal impacts 1,000 jobs, 50 local
at bizjournals.com - Fri Jul 31
·Teva Proves Its Decade-Hold Status With Massive Funding
- Fri Jul 31
·Eagle Pharmaceuticals to Discuss Second Quarter 2015 Financial Results on August 11, 2015
Business Wire - Fri Jul 31
·Mylan Inc. -- Moody's Affirms Mylan's Baa3; outlook changed to negative from developing
- Fri Jul 31
·Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering PENNSAID(R) (diclofenac sodium topical solution) 2%
Marketwire - Fri Jul 31
Thursday, Jul 30, 2015
·No Rush to Hop on M&A Bandwagon, Says Gilead Sciences CFO
at The Wall Street Journal Online - Thu Jul 30
·Pacira Pharmaceuticals, inc. Earnings Send Its Shares Soaring 10% Earlier Today
at Motley Fool - Thu Jul 30
·Oculus Innovative Sciences Reports Financial Results for the First Quarter of Fiscal Year 2016
GlobeNewswire - Thu Jul 30
·From Actavis to Allergan: One pharma company’s wild dealmaking journey
at Fortune - Thu Jul 30
·Former Allergan CEO is still going after Pershing
at CNBC - Thu Jul 30
·NBIX: Three More Data Readouts Coming in the Second Half of 2015…
- Thu Jul 30
·Pacira meets 2Q profit forecasts
AP - Thu Jul 30
·Flexion Therapeutics to Report Second-Quarter 2015 Financial Results on August 6, 2015
GlobeNewswire - Thu Jul 30
·Teva's MS drug Copaxone has strong second-quarter sales
Reuters - Thu Jul 30
·Evoke Pharma Schedules Webcast and Conference Call for Second Quarter 2015 Financial Results
GlobeNewswire - Thu Jul 30
·Depomed Rejected Horizon Pharma's Takeout Bid, But Still Trades As If M&A Is Happening
- Thu Jul 30
More Latest News...
Sponsor Results
Xenograft Preclinical CRO
We generate NOD/Nude xenografts Contract Research Laboratory (GLP)
www.AltogenLabs.com
Cystic Fibrosis
Have a baby with CF? Gets Support, Join our Online Community.
www.ezHealthMD.com
Clinical Trial
Go To Local.com To Find An Oncologist In Your Area!
Local.com/Clinical Trial
(What's This?)
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drugs - Generic Headlines
More Finance RSS Feeds


Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2015, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?